Clarinex RediTabs
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough's Clarinex (desloratadine) RediTabs formulation has been approved for the treatment of allergic rhinitis and chronic idiopathic urticaria, FDA announces July 15. The Claritin (loratadine) follow-on is currently prescription-only. The RediTabs formulation disintegrates orally for once-daily 24-hour relief. Clarinex RediTabs will be available in pharmacies September 2005 in a 2.5 mg and 5 mg dose. The tablet also comes in a new "tutti frutti" flavor...